Warts Therapeutics Market Developments and Forecast by 2028

The warts therapeutics market was valued US$ 1,829.54 million in 2021, it is estimated to grow at a CAGR of 3.4% from 2021 to 2028.

The growth of the warts therapeutics market is attributed to rising prevalence of human papillomavirus infections and recurrence of genital warts, and development of new products. However, poor diagnostics scenario in low-income countries restrains the market growth. Warts are skin growth caused by the human papillomaviruses (HPV). There are more than 60 types of HPVs, and several of these tend to cause warts on the skin. Although topical treatments could probably resolve the issue of warts in a few weeks with minimal side effects, they may not be effective all the time. Hence, cryotherapy with liquid nitrogen is a suitable option for treatment, where cure rate is 60–90% and less than 10–20% recurrence rate.

In the US, the demand for warts treatment procedures has reduced due to the shift in focus on COVID-19. The pandemic has been causing havoc in the global supply chains, consumer markets, and economies as a whole. As a result of the measures implemented by governments around the world have negatively impacted the warts therapeutics market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Warts Therapeutics Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Market Insights

Rising Prevalence of Human Papillomavirus Infections and Recurrence of Genital Warts Fuel Warts Therapeutics Market Growth

Warts are caused by various strains of human papillomaviruses (HPV), and different strains cause warts in different parts of the body. Healthy persons coming in contact with warts can acquire the infection. As per the Centers for Disease Control and Prevention (CDC), in 2018, ~20% of the population, i.e., ~42.5 million people, in the US had sexually transmitted infections (STIs). In addition, before HPV vaccination, genital warts affected ~340,000–360,000 women and men in the US annually. Moreover, the recurrence rate for genital warts is high. As per the National Center for Biotechnology Information (NCBI), ~30% of total warts cases globally are expected to regress within the first four months of infection. In addition, HPV infections lead to cervical cancer, and cervical cancer is the fourth most common cancer among women globally. As per the World Health Organization (WHO), ~570,000 new cases of cervical cancer recorded in 2018 with high prevalence in low-income countries. Hence, an increase in the prevalence of HPV infections, leading to a rise in wart cases, and the high recurrence rate of warts are driving the wart therapeutics market growth.

Type-Based Insights

Based on type, the warts therapeutics market is further segmented into common warts, genital warts, flat warts, and others. The common warts segment holds the largest share of the market. However, the genital warts segment is anticipated to register the highest CAGR during 2021–2028. Genital warts refer to sexually transmitted infection that are usually caused due to HPV. The increasing prevalence of STDs and growing research and development efforts to develop genital warts treatment options would propel the market growth of this segment in the coming years.

Treatment - Based Insights

Based on treatment, the warts therapeutics market is further segmented into physical destruction, immunomodulation, and chemical destruction. The market for physical destruction is further segmented into cryotherapy, surgical removal, and laser treatment. The immunomodulation is sub segmented into interferons, retinoids, and zinc. The chemical destruction segment is further divided into bleomycin, cantharidin, salicylic acid, and others. The physical destruction segment holds the largest share of the warts therapeutics market and is anticipated to register the highest CAGR in the market during the forecast period.

End User-Based Insights

Based on end user, the warts therapeutics market is segmented into hospitals, homecare, specialty clinics, and others. The hospitals segment holds the largest market share. However, the homecare segment is estimated to register the highest CAGR during the forecast period. The projected market growth for this segment can be attributed to the increasing number of hospitals across the world, and rapidly growing number of surgical procedures.
         
Companies operating in the warts therapeutics market are adopting the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

Warts Therapeutics Market Regional Insights

The regional trends and factors influencing the Warts Therapeutics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Warts Therapeutics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Warts Therapeutics Market Report Scope

Warts Therapeutics Market Players Density: Understanding Its Impact on Business Dynamics

The Warts Therapeutics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Warts Therapeutics Market – by Type

• Common Warts
• Genital Warts
• Flat Warts
• Others

Warts Therapeutics Market – by Treatment

• Physical Destruction 
  • Cryotherapy
  • Surgical Removal
  • Laser Treatment
• Immunomodulation
  • Interferons
  • Retinoids
  • Zinc
• Chemical Destruction
  • Bleomycin
  • Cantharidin
  • Salicylic Acid
  • Others

Warts Therapeutics Market – by End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Warts Therapeutics Market– by Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of APAC
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM

Company Profiles

• Bausch Health Companies Inc.      
• Nielsen BioSciences, Inc.    
• Euro Vital Pharma GmbH    
• Cipla Inc.     
• Koninklijke Utermöhlen NV           
• Novan, Inc.            
• Scholl's Wellness Company           
• TEVA PHARMACEUTICAL INDUSTRIES LTD          
• Verrica Pharmaceuticals Inc.        
• GlaxoSmithKline plc.          
• AIM ImmunoTech Inc